FDA Investigator Lourdes R Genera
Lourdes R Genera has conducted inspections on 109 sites in 1 countries as of 30 Aug 2016. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
109
Last Inspection Date:
30 Aug 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lourdes R Genera:
Adam C Hipko,
Adrian Rodriguez,
Akbar J Zaidi,
Albert F Peacock, PhD,
Alcee M Tavarez,
Andrew J Lang,
Angela Mock,
Anh M Lac,
Anya Dlockett Evans,
Aqualia L Nelson,
Arie R Dyk,
Ashley N Williams,
Betsy C Galliher,
Bing Lin,
Blondell W Johnson,
Bonnie L Menzel,
Brackens Harris,
Brandi E Williams,
Brandon K Barbee,
Brandon K Lawson,
Brian P Hendrickson,
Brian R Yaun,
Brook Shea,
Camille D Brown,
Carol A Declouette Wilburn,
Carol F Robinson,
Casey L Hamblin,
Cassandra L Abellard,
Cathleen A Castellaw,
Chad J Whitwell,
Charles B Steinmiller,
Charles D Brown,
Christine L Williams,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher L Jacobs,
Coleen L Manoy,
Connie L Hannon Rabel,
Crystal A Harlan,
Crystal S Harris,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Darla J Christopher,
David M Beltran,
Debbie J Cunningham,
Decarlos A Gomez,
Denise Connelly,
Deniza Karacic,
Diane Hall,
Dirk L Lincoln,
Dr. Jason R Caballero,
Ed Gonzalez Vazquez,
Edmiston,
Elisa M Fleming,
Elizabeth D Connell,
Elmina E Akwo,
Elmina E Mboh,
Enspect User,
Esther A Ofori,
Fernando C Martinez,
Frans E Mercado,
Gatica,
Gery M Duparc,
Glasgow Glasgow,
Grant L Davis,
Gretchen M Laws,
Hung V Le,
J Elkins,
Jacob W Reynolds,
James C Warren,
Jamie M Bumpas,
Janice M Hickok,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer Hua,
Jennifer O Dowdy,
Jocelyn C Turner,
Jodi M Gatica,
Jogy George,
Johann M Fitch,
Johnson,
Jonaida Estevez Martinez,
Jonathan A Womack,
Jose Martinez, Jr,
Joy L Ramsey,
Juan D Lopez,
Kaarin M Slotte,
Kamara Tx,
Karen C Daugherty,
Karlton T Watson,
Kathleen Chmura Shaffer,
Kenitra D Hewitt,
Kevin T Nguyen,
Khunnathee Stoner,
Kip J Hanks,
Kristen E Szenderski,
Kristin N Longfellow,
Kunapuli T Madhusudhan,
L Grant,
Latorie S Jones,
Lauren M Lilly, PhD,
Lauren R Brady,
Lawrence C Coleman,
Lawrence C Prine,
LCDR Ismael Olvera, IV,
Lisa M Puttonen,
Lisa M Yoder,
Lisa R Jennings,
Liza L Quiles,
Lloyd D Payne,
Lorie S Hannappel,
Maira P Brading,
Marc R Dickens,
Margaret M Annes,
Maria Elenagamble Rs,
Martha S Baldwin,
Martin K Essary,
Massoud Motamed,
Merelynn Rhoten,
Michael D Porter,
Michelle C Webb,
Michelle Paxon,
Monica J Wilkins,
Monique Rac Lester,
Monique S Frazier,
Nimmy Mathews,
Ninfa N Innocent,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul E Frazier,
Paula J Perry,
Pauline N Logan,
Payne,
Philip M Steele, PhD,
Phillip J Sample,
Pitman,
Rebecca L Mullikin,
Rendall E Barfoot,
Robert T Harris,
Robert T Lorenz,
Ronda Rloyd Jones,
Rowena Trevino Solis,
Roy Baby,
Saleem A Akhtar,
Samuel A Hamblin,
Sandy J Ziegler,
Sara A Valenzuela,
Scott A Hendrix,
Scott R Nichols, PhD,
Scott T Ballard,
Selina M Mata,
Seri L Essary,
Sha'tina R Alridge,
Shanna N Purdy,
Shannon A Lowe,
Shelby N Turner,
Sherrie L Krolczyk,
Shusheen A Alexander,
Staci G Mcallister,
Stephanie D Crockett,
Stephen D Brown,
Stephen L Beekman,
Sunitha K Rajaram, PhD,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Thomas Martinez,
Timothy B Webb,
Timothy H Vo,
Toby Vern H Hill,
Torrance J Slayton,
Tracy J Washington,
Travis M Beard,
Travis R Hunt,
Travis S Brown,
Tricia S Martinez,
Trina K Vick,
Verlinda A Narcisse,
William F Lagud, Jr,
Yaw O Osei,
Young M Yoon
Lourdes R Genera's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2014 | FDA 483 | AmWiner & Raphe Holdings LLC - Form 483, 2014-02-21 |
December, 2012 | FDA 483 | Ampharmco, LLC - Form 483, 2012-12-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more